Literature DB >> 10980241

Mechanisms governing the differentiation of a serotonergic phenotype in culture.

J Zhou1, L Iacovitti.   

Abstract

In this study, we explored whether a serotonergic (5-HT) phenotype could be novelly induced in the phenotypically plastic neurons of the developing striatum. We found that the 5-HT biosynthetic enzyme tryptophan hydroxylase (TPH) was expressed in nearly 10% of neurons following treatment with an extract derived from adult raphe tissue. This effect was mimicked by co-treatment with a growth factor (aFGF, bFGF or BDNF; but not GDNF, IGF-1, EGF or TGF) and the neurotransmitter 5-HT (but not GABA, dopamine, glutamate) and/or a protein kinase activator (IBMX, forskolin, TPA). Treatment with combined factors (aFGF+5-HT+IBMX+forskolin+TPA) yielded the greatest level of TPH induction (15.6%). Moreover, TPH was enzymatically active (112.8+/-36 pmol/mg per h) and produced detectable levels of 5-HT (2.12+/-0.30 ng) and its metabolite 5-HIAA (4.24+/-0.11 ng) in maximally stimulated cultures. These findings demonstrate that it is possible to promote the differentiation of serotonergic phenotypic traits in developing brain neurons in culture.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10980241     DOI: 10.1016/s0006-8993(00)02624-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  2 in total

1.  Descending 5-hydroxytryptamine raphe inputs repress the expression of serotonergic neurons and slow the maturation of inhibitory systems in mouse embryonic spinal cord.

Authors:  Pascal Branchereau; Jacqueline Chapron; Pierre Meyrand
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

2.  Gender-dependent modulation of brain monoamines and anxiety-like behaviors in mice with genetic serotonin transporter and BDNF deficiencies.

Authors:  Renee F Ren-Patterson; Lauren W Cochran; Andrew Holmes; Klaus-Peter Lesch; Bai Lu; Dennis L Murphy
Journal:  Cell Mol Neurobiol       Date:  2006-09-22       Impact factor: 5.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.